NDAINTRAVENOUSSOLUTION
Approved
Feb 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
IDAMYCIN PFS (idarubicin hydrochloride) by Pfizer is dna, inhibiting nucleic acid synthesis, inhibiting topoisomerase ii activity, and producing dna-damaging free radicals. First approved in 1997.
Drug data last refreshed 10h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IDAMYCIN PFS is an intravenous anthracycline chemotherapy agent containing idarubicin hydrochloride, approved in 1997 for hematologic malignancies. It works by intercalating into DNA, inhibiting nucleic acid synthesis, inhibiting topoisomerase II activity, and generating DNA-damaging free radicals to kill rapidly dividing cancer cells.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling shift from growth investment to lifecycle management and generic transition planning.
Mechanism of Action
DNA, inhibiting nucleic acid synthesis, inhibiting topoisomerase II activity, and producing DNA-damaging free radicals.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on IDAMYCIN PFS offers limited growth but deep expertise in oncology, hematology, and chemotherapy management in a mature market. Roles focus on defensive market positioning, pricing strategy, and operational efficiency as the product approaches loss of exclusivity.
Brand ManagerRegional Sales Manager
Worked on IDAMYCIN PFS at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.